Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Shenzhen Hepalink Pharma Invests $60M In TPG Biotech Fund
Venture Capital

Shenzhen Hepalink Pharma Invests $60M In TPG Biotech Fund

by chinamoneynetwork.com posted 2years ago 5150 views
Chinese drug maker Shenzhen Hepalink Pharmaceutical plans to invest US$60 million in TPG Biotechnology Partners V, L.P., which mainly targets biomedical technology and life science companies, the company announced in a statement (in Chinese).